Figure 2

Chemosensitivity rank. Frequency of drug expectation rank based on GI 50 . (A) Ascites and (B) Solid tumors. (C) Frequency of drug resistance defined by a hyperbolic pattern of dose–response curves. GI50, concentration of a drug for which growth is reduced by 50% compared to the untreated control.